Agendia Presents New Data Demonstrating MammaPrintโs Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress
Irvine, California โ September 17, 2020 โ Agendia, Inc., a Read More